Acrylamide, a chemical compound with both genotoxic and carcinogenic properties, continues to raise health concerns due to its presence in various foods. Despite mitigation efforts post-2003 aimed at reducing acrylamide levels in specific high-risk foods, average dietary exposure among the general population remains unchanged. This article delves into the implications of dietary acrylamide exposure, the associated health risks, and the findings of recent scientific evaluations.
Understanding Acrylamide and Its Risks
Acrylamide is formed in certain foods during high-temperature cooking processes, such as frying, roasting, and baking. It is particularly prevalent in starchy foods like potatoes, bread, and coffee. Due to its genotoxic and carcinogenic nature, acrylamide poses significant health risks, including potential neurological effects and cancer.
The Joint FAO/WHO Expert Committee on Food Additives (JECFA) has conducted extensive evaluations to assess the risk posed by acrylamide in the diet. Their findings highlight the compound’s adverse effects, particularly at high exposure levels.
Mitigation Efforts and Exposure Levels
Efforts to reduce acrylamide levels in food have been reported since 2003. These measures target food types with high acrylamide content or specific products within those categories. However, the overall impact on the general population’s dietary exposure appears minimal. The estimated average exposure for the general population remains at 0.001 mg/kg body weight (bw) per day, while high-percentile consumers experience an exposure of 0.004 mg/kg bw per day.
Margins of Exposure and Health Implications
The Margin of Exposure (MOE) is a crucial metric in assessing health risks. It is calculated by comparing the exposure levels to the No Observed Adverse Effect Level (NOAEL) or the Benchmark Dose Lower Confidence Limit (BMDL10). For acrylamide, the NOAEL for morphological changes in nerves, identified through electron microscopy in rats, is 0.2 mg/kg bw per day. The MOE values for the general population and high-percentile consumers are 200 and 50, respectively. These figures indicate that while average exposure is unlikely to cause adverse neurological effects, high exposure could potentially lead to morphological changes in nerves.
When comparing dietary exposures to the BMDL10 for cancer endpoints, the MOE values further highlight health concerns. For the induction of mammary tumors in rats (BMDL10 of 0.31 mg/kg bw per day), the MOE values are 310 for average exposure and 78 for high exposure. For Harderian gland tumors in mice (BMDL10 of 0.18 mg/kg bw per day), the MOE values are 180 for average exposure and 45 for high exposure.
Consistent Findings and Ongoing Concerns
The Committee’s recent evaluations align with conclusions drawn at their sixty-fourth meeting. Despite the extensive new data from cancer bioassays in rodents, physiologically based pharmacokinetic (PBPK) modeling, numerous epidemiological studies, and updated dietary exposure assessments, the overall health risk assessment remains consistent. The MOE values continue to indicate a human health concern, particularly for individuals with high dietary exposure to acrylamide.
Conclusion
The persistence of acrylamide in the diet, despite mitigation efforts, underscores the need for continued vigilance and research. While average exposure levels may not pose significant neurological risks, high exposure levels could potentially lead to adverse effects, including morphological changes in nerves and increased cancer risk. The findings emphasize the importance of ongoing efforts to reduce acrylamide levels in food and protect public health.
Reference: https://apps.who.int (World Health Organization)
Johnson fitness ลู่วิ่งไฟฟ้า HORIZON OMEGA Z
Johnson fitness Matrix Treadmill ลู่วิ่งไฟฟ้าเกรดพรีเมียม รุ่น TF50 XR
